191 related articles for article (PubMed ID: 35176141)
1. Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study).
David C; Duployez N; Eloy P; Belhadi D; Chezel J; Guern VL; Laouénan C; Fenwarth L; Rouzaud D; Mathian A; de Almeida Chaves S; Duhaut P; Fain O; Galicier L; Ghillani-Dalbin P; Kahn JE; Morel N; Perard L; Pha M; Sarrot-Reynauld F; Aumaitre O; Chasset F; Limal N; Desmurs-Clavel H; Ackermann F; Amoura Z; Papo T; Preudhomme C; Costedoat-Chalumeau N; Sacre K
Rheumatology (Oxford); 2022 Nov; 61(11):4355-4363. PubMed ID: 35176141
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Disease Among Patients With AML and CHIP-Related Mutations.
Calvillo-Argüelles O; Schoffel A; Capo-Chichi JM; Abdel-Qadir H; Schuh A; Carrillo-Estrada M; Liu S; Gupta V; Schimmer AD; Yee K; Shlush LI; Natarajan P; Thavendiranathan P
JACC CardioOncol; 2022 Mar; 4(1):38-49. PubMed ID: 35492819
[TBL] [Abstract][Full Text] [Related]
3. Highly sensitive serum cardiac troponin T and cardiovascular events in patients with systemic lupus erythematosus (TROPOPLUS study).
Chezel J; Costedoat-Chalumeau N; Laouénan C; Rouzaud D; Chenevier-Gobeaux C; Le Guern V; Mathian A; Belhadi D; de Almeida Chaves S; Duhaut P; Fain O; Galicier L; Ghillani-Dalbin P; Kahn JE; Morel N; Perard L; Pha M; Saidoune F; Sarrot-Reynauld F; Aumaitre O; Chasset F; Limal N; Desmurs-Clavel H; Ackermann F; Amoura Z; Papo T; Sacre K
Rheumatology (Oxford); 2021 Mar; 60(3):1210-1215. PubMed ID: 32901293
[TBL] [Abstract][Full Text] [Related]
4. TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial.
Svensson EC; Madar A; Campbell CD; He Y; Sultan M; Healey ML; Xu H; D'Aco K; Fernandez A; Wache-Mainier C; Libby P; Ridker PM; Beste MT; Basson CT
JAMA Cardiol; 2022 May; 7(5):521-528. PubMed ID: 35385050
[TBL] [Abstract][Full Text] [Related]
5. Predisposing factors to nonfatal cardiovascular events in women with systemic lupus erythematosus. An observational, cross-sectional, multicenter study in Spain from the risk/systemic lupus erythematosus thematic network.
Fernández-Garcés M; Haro G; Micó ML
Medicine (Baltimore); 2019 Oct; 98(43):e17489. PubMed ID: 31651851
[TBL] [Abstract][Full Text] [Related]
6. Maternal-placental syndrome and future risk of accelerated cardiovascular events in Parous Swedish women with systemic lupus erythematosus - a population-based retrospective cohort study with time-to-event analysis.
Soh MC; Dib F; Nelson-Piercy C; Westgren M; McCowan L; Pasupathy D
Rheumatology (Oxford); 2016 Jul; 55(7):1235-42. PubMed ID: 27016663
[TBL] [Abstract][Full Text] [Related]
7. Clonal haematopoiesis of indeterminate potential: associations with heart failure incidence, clinical parameters and biomarkers.
Shi C; Aboumsallem JP; Suthahar N; de Graaf AO; Jansen JH; van Zeventer IA; Bracun V; de Wit S; Screever EM; van den Berg PF; Meijers WC; Gansevoort RT; Bakker SJL; van der Harst P; Silljé HHW; Huls G; de Boer RA
Eur J Heart Fail; 2023 Jan; 25(1):4-13. PubMed ID: 36221810
[TBL] [Abstract][Full Text] [Related]
8. Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Behçet's disease.
Park J; An H; Lim J; Park IS; Kim MH; Kim JH; Kim SW; Koh YI; Lee EY; Cheon JH
Arthritis Res Ther; 2023 Mar; 25(1):33. PubMed ID: 36864496
[TBL] [Abstract][Full Text] [Related]
9. Clonal Hematopoiesis of Indeterminate Potential (CHIP) and Incident Type 2 Diabetes Risk.
Tobias DK; Manning AK; Wessel J; Raghavan S; Westerman KE; Bick AG; Dicorpo D; Whitsel EA; Collins J; Correa A; Cupples LA; Dupuis J; Goodarzi MO; Guo X; Howard B; Lange LA; Liu S; Raffield LM; Reiner AP; Rich SS; Taylor KD; Tinker L; Wilson JG; Wu P; Carson AP; Vasan RS; Fornage M; Psaty BM; Kooperberg C; Rotter JI; Meigs J; Manson JE;
Diabetes Care; 2023 Nov; 46(11):1978-1985. PubMed ID: 37756531
[TBL] [Abstract][Full Text] [Related]
10. A new risk factor associated with cardiovascular disease: clonal hematopoiesis of indeterminate potential.
Yu X; Qian N; Wang Y
Mol Biol Rep; 2023 Mar; 50(3):2813-2822. PubMed ID: 36595120
[TBL] [Abstract][Full Text] [Related]
11. Interferon Inhibition for Lupus with Anifrolumab: Critical Appraisal of the Evidence Leading to FDA Approval.
Loncharich MF; Anderson CW
ACR Open Rheumatol; 2022 Jun; 4(6):486-491. PubMed ID: 35157371
[TBL] [Abstract][Full Text] [Related]
12. Birth Weight Is Associated With Clonal Hematopoiesis of Indeterminate Potential and Cardiovascular Outcomes in Adulthood.
Schuermans A; Nakao T; Ruan Y; Koyama S; Yu Z; Uddin MM; Haidermota S; Hornsby W; Lewandowski AJ; Bick AG; Niroula A; Jaiswal S; Ebert BL; Natarajan P; Honigberg MC
J Am Heart Assoc; 2023 Jul; 12(13):e030220. PubMed ID: 37345823
[TBL] [Abstract][Full Text] [Related]
13. Clonal haematopoiesis is increased in early onset in systemic sclerosis.
Ricard L; Hirsch P; Largeaud L; Deswarte C; Jachiet V; Mohty M; Rivière S; Malard F; Tenon M; de Vassoigne F; Fain O; Gaugler B; Rossignol J; Delhommeau F; Mekinian A;
Rheumatology (Oxford); 2020 Nov; 59(11):3499-3504. PubMed ID: 32757002
[TBL] [Abstract][Full Text] [Related]
14. Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study.
Gustafsson J; Gunnarsson I; Börjesson O; Pettersson S; Möller S; Fei GZ; Elvin K; Simard JF; Hansson LO; Lundberg IE; Larsson A; Svenungsson E
Arthritis Res Ther; 2009; 11(6):R186. PubMed ID: 20003285
[TBL] [Abstract][Full Text] [Related]
15. Clonal haematopoiesis of indeterminate potential-related mutations and outcome in dilated and ischaemic cardiomyopathy.
Wu JMF; Bekfani T; Hinze A; Westphal JG; Steinacker B; Zeller M; Hartmann C; Möbius-Winkler S; Hochhaus A; Schulze PC; Ernst T
ESC Heart Fail; 2022 Dec; 9(6):3954-3960. PubMed ID: 35979940
[TBL] [Abstract][Full Text] [Related]
16. Somatic mutation contributing to clonal haematopoiesis is a risk factor of recurrent stroke in first-ever acute ischaemic stroke: a prospective cohort study.
Qiu X; Dai Y; Cheng S; Gu HQ; Jiang Y; Meng X; Wang Y; Zhao X; Jiang Y; Xu Z; Huang X; Wang M; Lyu TJ; Wang Y; Weng J; Cui L; Shangguan Y; Li H; Wang Y; Li Z
Stroke Vasc Neurol; 2023 Apr; 8(2):103-110. PubMed ID: 36137598
[TBL] [Abstract][Full Text] [Related]
17. Clonal Hematopoiesis of Indeterminate Potential in Chronic Thromboembolic Pulmonary Hypertension: A Multicenter Study.
Liu C; Zhou YP; Lian TY; Li RN; Ma JS; Yang YJ; Zhang SJ; Li XM; Qiu LH; Qiu BC; Ren LY; Wang J; Han ZY; Li JH; Wang L; Xu XQ; Sun K; Chen LF; Cheng CY; Zhang ZJ; Jing ZC
Hypertension; 2024 Feb; 81(2):372-382. PubMed ID: 38116660
[TBL] [Abstract][Full Text] [Related]
18. Somatic Mutations and Clonal Hematopoiesis as Drivers of Age-Related Cardiovascular Risk.
Haring B; Wissel S; Manson JE
Curr Cardiol Rep; 2022 Aug; 24(8):1049-1058. PubMed ID: 35657494
[TBL] [Abstract][Full Text] [Related]
19. Clonal Hematopoiesis and Cardiovascular Diseases: The Connection.
Mozzini C; Pagani M
Curr Probl Cardiol; 2022 Oct; 47(10):100962. PubMed ID: 34391764
[TBL] [Abstract][Full Text] [Related]
20. [Clonal haematopoiesis: A concise review].
Danlos FX; Papo M; Micol JB
Rev Med Interne; 2019 Oct; 40(10):684-692. PubMed ID: 31126662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
